Outcome of gastric antral vascular ectasia and related anemia after orthotopic liver transplantation

Table 1 Clinical characteristics of patients with gastric antral vascular ectasia who underwent orthotopic liver transplantation

Patient No.	Age	Gender	BMI	Etiology of liver disease	MELD-Na score at GAVE diagnosis	Pre-OLT Hgb (g/dL)	GAVE pattern	Endoscopic therapy	Resolution of GAVE post-OLT
1	66	F	33.7	NASH	26	8	Diffuse punctate GAVE	APC	Yes
2	55	F	28	cryptogenic	15	8.7	Pre-OLT: Striped GAVEPost-OLT: Nodular polypoid GAVE with exudate	None	No
3	50	M	42.7	NASH	32	7	Linear/striped GAVE	APC	Yes
4	57	F	32.9	cryptogenic	13	7.2	Striped and nodular GAVE	Banding	Yes
5	59	F	35.7	NASH	14	6.7	Pre and post-OLT: Nodular polypoid GAVE with exudate	Banding	No
6	51	M	23	Alcohol	30	7.1	Diffuse punctate GAVE	APC	Yes
7	51	M	27	NASH	23	7.2	Diffuse punctate GAVE	APC	Yes
8	57	F	22	Alcohol	23	7.5	Diffuse punctate GAVE	None	Yes
9	59	F	32.6	NASH	31	7.7	Diffuse punctate GAVE	Banding	Yes
10	40	M	36.6	Alcohol, HCV	Post-OLT diagnosis	6.9	Post-OLT: Linear striped; then polypoid GAVE	None	No
11	55	M	30.8	PSC	13	8.8	Nodular polypoid GAVE with exudate	None	Yes
12	58	M	17.8	Alcohol	12	7.3	Diffuse punctate GAVE	None	Yes
13	62	F	47.6	HCV	30	7.6	Linear/striped GAVE	None	Yes
14	57	F	25.5	Budd Chiari syndrome	Post-OLT diagnosis		Post-OLT: Patchy mild punctate GAVE	None	No
15	67	F	35.5	NASH	15	9.6	Patchy mild punctate GAVE	None	Yes
16	60	F	32.5	NASH	8	7.5	Linear/striped GAVE	APC	Yes

APC: Argon Plasma Coagulation; BMI: Body mass index; F: Female; GAVE: Gastric antral vascular ectasia; HCV: Hepatitis C virus; Hgb: Hemoglobin; M: Male; MELD-Na: Model for End-Stage Liver Disease- Sodium level; NASH: Non-alcoholic Steatohepatitis; OLT: Orthotopic liver transplantation; PSC: Primary sclerosing cholangitis.